sthrn labs is launching soon. Browse the catalog, review our COAs, and inquire to order.
Sermorelin
Sermorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) studied for its effects on endogenous GH secretion in preclinical research models. For research use only.
Compound information
What is Sermorelin?
Stability information
Research highlights
GHRH receptor agonism
Research on this 29-amino-acid GHRH analog and pituitary GH stimulation.
Endogenous GH preservation
Studies on stimulating the body's own GH production while preserving feedback regulation.
Age-related GH decline
Investigating restoration of GH/IGF-1 axis activity in aging models.
Pulsatile physiology
Exploration of natural, pulse-like GH secretion versus exogenous administration.
Sources & references
Sermorelin: a better approach to management of adult-onset growth hormone insufficiency?
Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men
All citations link directly to primary literature. sthrn labs does not reproduce, excerpt, or summarize article content.
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
